Kura Oncology, Inc. entered into an underwriting agreement for a public offering of common stock and pre-funded warrants, with expected net proceeds of approximately $93.6 million.
AI Assistant
KURA ONCOLOGY INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.